Stay updated on Pembrolizumab in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Solid Tumors Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedCore content updated with a government funding notice and a new version number (v3.2.0) replacing the old one (v3.1.0); reflects status and version changes rather than substantive feature additions.SummaryDifference7%
- Check24 days agoChange DetectedMajor version update to v3.1.0 with a new study status entry and date; older revision v3.0.2 and its date removed.SummaryDifference0.9%
- Check38 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2, indicating a new release, and the 'Back to Top' element was removed; overall, core content remains unchanged.SummaryDifference0.4%
- Check46 days agoChange DetectedThe web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.4%
- Check53 days agoChange DetectedThe web page has been updated to include a new facility name and location, along with several study status updates and dates, while some location-related terms and specific dates have been removed.SummaryDifference91%
- Check67 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.3%
Stay in the know with updates to Pembrolizumab in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Solid Tumors Clinical Trial page.